Cyclophosphamide + tumor necrosis factor-alpha

  • 1 lab in 1 country
  • Funder: National Cancer Institute
  • Animals1

Outcomes

1

CD4-CD8+CD44+ thymocytes

upin mice1

1 study
  1. Cyclophosphamide + tumor necrosis factor-alpha increases CD4-CD8+CD44+ thymocytes in mice.

    “Their thymocytes, exposed to X-irradiated EL4, developed anti-EL4 lytic activity and, in comparison with thymocytes of young and age-matched control mice, were markedly enriched in CD4-CD8+CD44+ cells.”

    Animalsthymus

    Thymic anti-tumor effectors in mice cured of lymphoma by cyclophosphamide plus TNF-alpha therapy: phenotypic and functional characterization up to 20 months after initial tumor inoculation

    International journal of cancer18 May 1998

More on CD4-CD8+CD44+ thymocytes

Latest